DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Symphogen announces new capital raise and explores strategic options 15 May 2019

Today, Symphogen called for an ordinary shareholders meeting to be held on 29 May 2019. At the meeting,... Read more

Y-mAbs Announces Development Update on Cancer Vaccine Program 15 May 2019

NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

DTU Biosustain joins new Global Biofoundries Alliance 15 May 2019

The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) joins the Global Biofoundries... Read more

Danish biotech company announces the completion of a €5.5 M seed investment 25 March 2019

The big Chinese fine chemical company Zhejiang NHU invest €5.5 M in the biotech start-up CysBio to... Read more

Acesion Pharma receives 5M DKK from Innovation Fund Denmark to support human Proof-of-Concept study in Atrial Fibrillation (AF) 13 March 2019

COPENHAGEN, Denmark — 12 March 2019: Acesion Pharma (“Acesion” or the Company), a Danish biotech... Read more

<img width="300" height="65" class="logoImg animateRtGeneral" src="https://danskbiotek.dk/wp-content/uploads/2019/02/Vaccibody-image-300x65.png" />

Vaccibody announces collaboration to study VB10.16 and atezolizumab (Tecentriq®) in advanced cervical cancer 19 February 2019

Oslo, Norway, 13 February, 2019 Vaccibody AS, a clinical stage immuno-oncology company, announced today... Read more

<img width="300" height="65" class="logoImg animateRtGeneral" src="https://danskbiotek.dk/wp-content/uploads/2019/02/Vaccibody-image-300x65.png" />

Vaccibody AS – NOK 230 million (EUR 23.6 million) private placement successfully placed 19 February 2019

Oslo, 14 February 2019 Reference is made to the press release by Vaccibody AS (“Vaccibody”... Read more

Y-mAbs Therapeutics to Present at PEGS Boston 14 February 2019

NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

MinervaX Announces Award of 4.4 Million Euro in Investment from Novo Holdings REPAIR Impact Fund and Sunstone Capital for Further Clinical Development of the Company’s Vaccine Against Group B Streptococcus (GBS) 21 January 2019

MinervaX, a privately held Danish biotech company, announces today that is has been awarded an in... Read more

Copyright 2019 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design